STOCK-BASED COMPENSATION (Details 2) (USD $) In Millions, except Share data, unless otherwise specified	6 Months Ended	12 Months Ended	1 Months Ended	6 Months Ended										12 Months Ended	6 Months Ended			3 Months Ended		6 Months Ended
	Dec. 31, 2013 Performance Share Units	Jun. 30, 2013 Performance Share Units	Sep. 30, 2013 Performance Share Units Common Class A	Dec. 31, 2013 Restricted Stock Units	Dec. 31, 2013 Restricted Stock Units RSU grants scheduled to vest in fiscal 2014	Dec. 31, 2013 Restricted Stock Units RSU grants scheduled to vest in fiscal 2015	Dec. 31, 2013 Restricted Stock Units RSU grants scheduled to vest in fiscal 2016	Dec. 31, 2013 Restricted Stock Units RSU grants scheduled to vest in fiscal 2017	Dec. 31, 2013 Restricted Stock Units RSU grants scheduled to vest in fiscal 2018	Dec. 31, 2013 Performance share units based on total stockholder return	Dec. 31, 2013 Performance share units based on total stockholder return Performance share units based on total stockholders return vesting (contractual term 33 months)	Dec. 31, 2013 Performance share units based on total stockholder return Performance share units based on total stockholders return vesting (contractual term 45 months)	Dec. 31, 2013 Performance share units based on total stockholder return Performance share units based on total stockholders return vesting (contractual term 57 months)	Jun. 30, 2013 Performance share units based on total stockholder return Common Class A Executive	Dec. 31, 2013 Performance share units based on total stockholder return Common Class A Maximum Executive	Dec. 31, 2013 Market Share Unit	Dec. 31, 2013 Share Units	Dec. 31, 2013 Cash Units	Dec. 31, 2012 Cash Units	Dec. 31, 2013 Cash Units	Dec. 31, 2012 Cash Units
Share-based Compensation Arrangement by Share-based Payment Award
Class A Common Stock issued for Performance Share Units (in shares)			548,800
Target payout for performance share units in Class A Common Stock (in shares)														162,760	260,416
Other Equity Compensation Plans
Nonvested at the beginning of the period (in shares)	510,900			2,222,800
Granted (in shares)	291,000			1,299,200
Vested (in shares)		(365,900)		(1,238,400)
Forfeited (in shares)				(36,200)
Nonvested at the end of the period (in shares)	801,900	510,900		2,247,400
RSU grants scheduled to vest (in shares)					300	475,100	487,000	333,800	3,000
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted-Average Grant Date Fair Value
Nonvested at the beginning of the period (in dollars per share)	$ 53.73			$ 52.68
Granted (in dollars per share)	$ 67.38			$ 66.02
Vested (in dollars per share)				$ 49.29
Forfeited (in dollars per share)				$ 57.58
Nonvested at the end of the period (in dollars per share)	$ 58.68	$ 53.73		$ 62.17
Grant date fair value (in USD)										$ 11.0						$ 10.6
Weighted-average expected option life											33 months	45 months	57 months
Number of shares outstanding																1
Method used for estimating grant date fair value										lattice model with a Monte Carlo						lattice model with a Monte Carlo
Contractual life																41 months
Weighted-average risk-free interest rate (as a percent)											0.30%	0.50%	0.70%			1.60%
Dividend yield (as a percent)										1.00%						1.00%
Weighted-average expected volatility (as a percent)										32.00%						29.00%
Non-Employee Director Plans
Outstanding at the beginning of the period (in shares)																	87,300
Granted (in shares)																	10,500
Dividend equivalents (in shares)																	500
Outstanding at the end of the period (in shares)																	98,300
Weighted-Average Grant Date Fair Value Per Share
Outstanding at the beginning of the period (in dollars per share)																	$ 33.27
Granted (in dollars per share)																	$ 70.68
Dividend equivalents (in dollars per share)																	$ 72.23
Outstanding at the end of the period (in dollars per share)																	$ 37.47
Non-employee Director Deferred Cash Compensation, Cash Payout Shares
Deferred compensation expense to reflect additional deferrals and change in market value (in dollars)																		$ 1.3	$ 0.1	$ 2.3	$ 1.5